Cabozantinib for Patients With Recurrent or Progressive Meningioma
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Recruiting · NCT05425004 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cabozantinib for Patients With Recurrent or Progressive Meningioma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer | Recruiting | Phase 2 | 2026-05-14 | NCT05425004 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baptist Health South Florida | 26 |
| Exelixis | 77 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York | United States | 1 |
| Miami Cancer Institute at Baptist Health, Inc. | Miami | United States | 22 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |